查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842256

美國馬人工授精市場：市場規模、佔有率、趨勢分析（按解決方案、馬匹品種和分銷管道分類）、細分市場預測（2025-2033 年）

U.S. Equine Artificial Insemination Market Size, Share & Trends Analysis Report By Solution (Equipment & Consumables, Semen, Services), By Equine (Sports/Racing, Recreation), By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

據估計，2024 年美國馬匹人工授精市場價值為 1.5544 億美元，預計到 2033 年將達到 2.4783 億美元，2025 年至 2033 年的複合年成長率為 5.41%。

受競技馬和休閒馬日益普及、馬匹獸醫基礎設施不斷完善以及監管和育種產業生態系統的支持，馬匹市場持續成長。美國擁有約920萬匹馬，它們在休閒、競技和工業馬匹產業中發揮著至關重要的作用。其中，近390萬匹馬參與休閒，約270萬匹馬參加馬術比賽。

為了確保幼駒擁有卓越的遺傳耐力、敏捷性和性情，馬主們擴大投資於人工授精（AI）。這種需求涵蓋了牛仔競技、繞桶賽、獵人跳躍賽和馬場馬術等多個馬術項目。透過提供廣泛且經過驗證的種公馬資源，人工授精有助於培育出適合各種競技需求的馬匹。休閒馬術產業的蓬勃發展，尤其是在德克薩斯州、肯塔基州和加州等州，持續推動人工授精技術的普及。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國馬匹人工授精市場：促進因素、趨勢與範圍

  • 市場關聯性展望
    • 母市場
    • 附隨市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國馬匹人工授精市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
  • 定價分析
  • 法律規範
  • 主要國家馬匹數量估計（2024 年）

第4章美國馬匹人工授精市場：依解決方案分類的估價與趨勢分析

  • 細分儀表板
  • 美國馬匹人工授精市場：按解決方案分類的變化分析
  • 美國馬匹人工授精市場規模及趨勢分析（按解決方案分類）（2021-2033 年）
  • 設備/耗材
  • 精液
  • 服務

第5章美國馬匹人工授精市場：按馬匹品種分類的估計和趨勢分析

  • 細分儀表板
  • 美國馬匹人工授精市場：依馬匹品種分類的趨勢分析
  • 美國馬匹人工授精市場規模及趨勢分析（按馬品種分類）（2021-2033 年）
  • 運動/賽車
  • 休閒
  • 其他

第6章：美國馬匹人工授精市場：通路估算與趨勢分析

  • 細分儀表板
  • 美國馬匹人工授精市場：按分銷管道分類的變化分析
  • 美國馬匹人工授精市場規模及趨勢分析（依通路分類）（2021-2033 年）
    • 私人的
    • 公共

第7章 競爭情勢

  • 市場參與企業分類
  • 企業市場分析/熱力圖分析
  • 公司簡介
    • Neogen Corporation
    • Zoetis Services LLC
    • HOFFMAN AI BREEDERS INC
    • Nasco Healthcare
    • IMV Technologies
    • Continental Genetics, LLC
    • Olympia Equine Veterinary Services PLLC
    • Sarasota Equine Veterinary Services
    • Montana Equine Medical and Surgical Center
    • Select Breeders Services
    • Equine Reproduction Concepts, LLC
    • Wisconsin Valley Veterinary Service
  • 策略規劃
    • 企業合併（M&A）
    • 商業夥伴關係與合作
    • 產品/服務發布
    • 其他
  • 其他主要企業名單
Product Code: GVR-4-68040-728-0

Market Size & Trends:

The U.S. equine artificial insemination market size was estimated at USD 155.44 million in 2024 and is projected to reach USD 247.83 million by 2033, growing at a CAGR of 5.41% from 2025 to 2033. The market is continuously growing, driven by the rising popularity of performance and recreational horses, expanding equine veterinary infrastructure, and a supportive regulatory and breeding industry ecosystem. The professional racing and competition, the growing popularity of recreational riding, show jumping, and Western performance events, are driving demand for high-quality horses in the U.S. The U.S. is home to around 9.2 million horses, playing a vital role in recreation, competition, and the broader equine industry. Among this population, nearly 3.9 million are engaged in recreational activities, while about 2.7 million participate in horse shows, reflecting the strong cultural and economic importance of equestrian pursuits nationwide.

Owners are increasingly investing in artificial insemination (AI) to secure foals with superior genetics for endurance, agility, and temperament. This demand spans disciplines such as rodeo, barrel racing, hunter/jumper circuits, and dressage. By enabling wider access to proven stallions, AI supports the breeding of horses suited to diverse performance needs. The expanding recreational equine sector, particularly in states like Texas, Kentucky, and California, continues to boost AI adoption.

U.S. Equine Artificial Insemination Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. equine artificial insemination market report based on solution, equine, and distribution channel:

  • Solution Outlook (Revenue, USD Million, 2021 - 2033)
  • Equipment & Consumables
  • Semen
    • Normal Semen
    • Sexed Semen
  • Services
  • Equine Outlook (Revenue, USD Million, 2021 - 2033)
  • Sports/Racing
  • Recreation
  • Other Type
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Private
  • Public

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
    • 1.3.6. Data analysis model
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Equine Artificial Insemination Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expanding equine veterinary infrastructure
      • 3.2.1.2. Rising popularity of performance and recreational horses
      • 3.2.1.3. Supportive regulatory and breeding industry ecosystem
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced reproductive procedures.
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Equine Artificial Insemination Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Legal landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Technological landscape
      • 3.3.2.6. Environmental landscape
  • 3.4. Pricing Analysis
  • 3.5. Regulatory Framework
  • 3.6. Estimated Equine Population by key countries, 2024

Chapter 4. U.S. Equine Artificial Insemination Market: Solution Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Equine Artificial Insemination Market: Solution Movement Analysis
  • 4.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by solution, 2021 to 2033 (USD Million)
  • 4.4. Equipment & Consumables
    • 4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Semen
    • 4.5.1. Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. Normal Semen
        • 4.5.1.1.1. Normal Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. Sexed Semen
        • 4.5.1.2.1. Sexed Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Equine Artificial Insemination Market: Equine Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Equine Artificial Insemination Market: Equine Movement Analysis
  • 5.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Equine, 2021 to 2033 (USD Million)
  • 5.4. Sports/Racing
    • 5.4.1. Sports/Racing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Recreation
    • 5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Equine Artificial Insemination Market: By Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Equine Artificial Insemination Market: By Distribution Channel Movement Analysis
  • 6.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 6.3.1. Private
      • 6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Public
      • 6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Market Position Analysis/ Heat Map Analysis
  • 7.3. Company Profiles
    • 7.3.1. Neogen Corporation
      • 7.3.1.1. Participant's Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product/Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Zoetis Services LLC
      • 7.3.2.1. Participant's Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product/Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. HOFFMAN A.I. BREEDERS INC
      • 7.3.3.1. Participant's Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product/Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Nasco Healthcare
      • 7.3.4.1. Participant's Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product/Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. IMV Technologies
      • 7.3.5.1. Participant's Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product/Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Continental Genetics, LLC
      • 7.3.6.1. Participant's Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product/Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Olympia Equine Veterinary Services PLLC
      • 7.3.7.1. Participant's Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product/Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Sarasota Equine Veterinary Services
      • 7.3.8.1. Participant's Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product/Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Montana Equine Medical and Surgical Center
      • 7.3.9.1. Participant's Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product/Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Select Breeders Services
      • 7.3.10.1. Participant's Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product/Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Equine Reproduction Concepts, LLC
      • 7.3.11.1. Participant's Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Product/Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Wisconsin Valley Veterinary Service
      • 7.3.12.1. Participant's Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Product/Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
  • 7.4. Strategy Mapping
    • 7.4.1. Mergers & Acquisitions
    • 7.4.2. Partnerships & Collaborations
    • 7.4.3. Product/Service launch
    • 7.4.4. Others
  • 7.5. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Equine Artificial Insemination Market, by Solution, 2021 - 2033 (USD Million)
  • Table 3 U.S. Equine Artificial Insemination Market, by Equine, 2021 - 2033 (USD Million)
  • Table 4 U.S. Equine Artificial Insemination Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 5 Company Overview
  • Table 6 Product Benchmarking
  • Table 7 Financial Performance
  • Table 8 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Equine Artificial Insemination Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. Equine Artificial Insemination Market snapshot
  • Fig. 11 U.S. Equine Artificial Insemination Market driver impact
  • Fig. 12 U.S. Equine Artificial Insemination Market restraint impact
  • Fig. 13 U.S. Equine Artificial Insemination species key takeaways (USD Million)
  • Fig. 14 U.S. Equine Artificial Insemination Market: solution, market share 2024 & 2033
  • Fig. 15 U.S. Equipment & Consumables market, 2021 - 2033 (USD Million)
  • Fig. 16 Semen market, 2021 - 2033 (USD Million)
  • Fig. 17 Normal market, 2021 - 2033 (USD Million)
  • Fig. 18 Sexed market, 2021 - 2033 (USD Million)
  • Fig. 19 Services market, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Equine Artificial Insemination equine key takeaways (USD Million)
  • Fig. 21 U.S. Equine Artificial Insemination Market: equine, market share 2024 & 2033
  • Fig. 22 Sports/Racing market, 2021 - 2033 (USD Million)
  • Fig. 23 Recreation market, 2021 - 2033 (USD Million)
  • Fig. 24 Others market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Equine Artificial Insemination market by Distribution Channel: Key takeaways
  • Fig. 26 U.S. Equine Artificial Insemination market by Distribution Channel, market share, 2024 & 2033
  • Fig. 27 Private market, 2021 - 2033 (USD Million)
  • Fig. 28 Public market, 2021 - 2033 (USD Million)
  • Fig. 29 Market participant categorization
  • Fig. 30 Market share of key market players U.S. Equine Artificial Insemination market